Chemistry: analytical and immunological testing – Heterocyclic carbon compound – Hetero-o
Reexamination Certificate
2009-11-16
2010-10-19
Wallenhorst, Maureen M (Department: 1797)
Chemistry: analytical and immunological testing
Heterocyclic carbon compound
Hetero-o
C436S161000, C436S174000, C210S656000
Reexamination Certificate
active
07816144
ABSTRACT:
Methods for analyzing mixtures of polysaccharides, for example heparin such as unfractionated heparin and enoxaparin are described. In some instances, the mixtures are analyzed using fast performance liquid chromatography (FPLC) and high liquid performance chromatography (HPLC), e.g., strong anion exchange HPLC.
REFERENCES:
patent: 4692435 (1987-09-01), Lormeau
patent: 5389618 (1995-02-01), Debrie
patent: 6617316 (2003-09-01), Mourier et al.
patent: RE38743 (2005-06-01), Debrie
patent: 7083937 (2006-08-01), Sasisekharan et al.
patent: 7585642 (2009-09-01), Sasisekharan et al.
patent: 2002/0169143 (2002-11-01), Sasisekharan et al.
patent: 2003/0203385 (2003-10-01), Venkataraman et al.
patent: 2004/0265943 (2004-12-01), Viskov et al.
patent: 2005/0119477 (2005-06-01), Mourier et al.
patent: 2005/0186679 (2005-08-01), Viskov et al.
patent: 2005/0215519 (2005-09-01), Viskov et al.
patent: 2005/0288252 (2005-12-01), Nurcombe et al.
patent: 2006/0024664 (2006-02-01), Sasisekharan et al.
patent: 2007/0065921 (2007-03-01), Sasisekharan et al.
patent: 2007/0098708 (2007-05-01), Myette
patent: 2007/0161073 (2007-07-01), Sasisekharan et al.
patent: 2007/0287683 (2007-12-01), Shriver et al.
patent: 2008/0009069 (2008-01-01), Mourier et al.
patent: 1580197 (2005-09-01), None
patent: 1582531 (2005-10-01), None
patent: 1586588 (2005-10-01), None
patent: WO 01/29055 (2001-04-01), None
patent: WO 03/078960 (2003-09-01), None
patent: WO 2004/027087 (2004-04-01), None
patent: WO 2005/009040 (2005-01-01), None
patent: WO 2005/080438 (2005-09-01), None
patent: WO 2005/090411 (2005-09-01), None
Desai et al., “Molecular weight of low molecular weight heparins by 13C nuclear magnetic resonance spectroscopy,” Carbohydrate Research, 255, (1994) pp. 193-212.
Malsch et al., “High-resolution capillary electrophoresis and polyacrylamide gel electophoresis of heparins,” Journal of Chromatography A. 716. (1995) pp. 258-268.
Sundaram et al., “Rational design of low-molecular weight heparins with improved in vivo activity,” PNAS, 100(2), Jan. 21, 2003, pp. 651-656.
Bianchini et al. “Few Bicyclic Acetals at Reducing End of Low-Molecular-Weight Heparins: Might they Restrict Specification of Pharmacopoeia?” Pharmeuropa Scientific Notes, 2005—1 pp. 1-3.
Bianchini et al. “Variability of Heparins and Heterogeneity of Low Molecular Weight Heparins” Seminars in Thrombosis and Hemostasis vol. 33, No. 5, 2007, pp. 496-502.
Cerny et al. “Preparation of 2-Amino-I ,6-Anhydro-2,3-Dideoxy-B-D-arabino-Hexopyranose. 1 H- and 13C-N.M.R. Spectra of Deoxy Derivatives of 2-Amino-I ,6-Anhydro-2-Deoxy-D-Glucose and 2-Amino-I ,6-Anhydro-2-Deoxy-D-Mannose.” Carbohydrate Research, 130 (1984) 103-114.
Fareed et al. “Generic Low-Molecular-Weight Heparins: Some Practical Considerations” Seminars in Thrombosis and Hemostasis. vol. 30, No. 6 2004 pp. 703-713.
Fareed et al. “Biochemical and Pharmacologic Heterogeneity in Low Molecular Weight Heparins. Impact on the Therapeutic Profile” Current Pharmaceutical Design, 2004 vol. 10, 983-999.
Guerrini et al. Low Molecular Weight Heparins: Structural Differentiation by Bidimensional nuclear magnetic Resonance Spectroscopy. Seminars in Thrombosis and Hemostasis. vol. 33, No. 5 2007 pp. 478-487.
Mascellani et al. “Characterization of di- and monosulfated, unsaturated heparin disaccharides with terminal N-sulfated 1 ,6-anhydro-B-D-glucosamine or N-sulfated 1 ,6-anhydro-B-D-mannosamine residues” Carbohydrate Research vol. 342 (2007) pp. 835-842.
Citizens Petition filed with the United States Food and Drug Administration by Aventis Pharmaceuticals Inc. on Feb. 19, 2003.
Citizens Petition Supplemental filed with the United States Food and Drug Administration by Aventis Pharmaceuticals Inc. on Feb. 12, 2004.
“2.6.26. Test for Anti-D Antibodies in Intravenous Immunoglobulin” Pharmeuropa vol. 16, No. 1, Jan. 2004 pp. 121-122.
Holzgrabe et al., Quantitative NMR spectroscopy—Applications in drug analysis. Journal of Pharmaceutical and Biomedical Analysis, 2005, V. 38, p. 806-812.
Hirano, S. NMR study of 4-deoxy-alpha—L-threo-4-enohexopyranosyluronic acid (1-3)2acetamido-2-deoxy-D-hexoses produced in the enzymic digestion of hyaluronate, chondroitin and chondroitin sulfates. Organic Magnetic Resonance, vol. 2, p. 577-580, 1970.
Ampofo, S. et al., “Disaccharide Compositional Analysis of Heparin and Heparan Sulfate Using Capillary Zone Electrophoresis,”Analytical Biochem.,199:249-255 (1991).
Da Col, R. et al., “Characterization of the Chemical Structure of Sulphated Glycosaminoglycans After Enzymatic Digestion. Application for Liquid Chromatography—Mass Spectrometry with an Atmospheric Pressure Interface,”J. of Chromatography,647:289-300 (1993).
Desai, U. et al., “Oligosaccharide Composition of Heparin and Low-molecular-weight Heparins by Capillary Electrophoresis,”Analytical Biochem.,213:120-127 (1993).
Ernst, S. et al., “Direct Evidence for Predominantly Exolytic Processive Mechanism for Depolymerization of Heparin-like Glycosaminoglycans by Heparinase I,”PNAS,95:4182-4187 (1998).
Guo, Y. et al., “The Disaccharide of Heparins and Heparan Sulfates,”Analytical Biochem.,176:96-104 (1989).
Imanari, T. et al., “High-performance Liquid Chromatographic Analysis of Glycosaminoglycan-derived Oligosaccharides,”J. of Chromatography A,720:275-293 (1996).
Karamanos, N. et al., “Ion-pair High-performance Liquid Chromatography for Determining Disaccharide Composition in Heparin and Heparan Sulphate,”J. of Chromatography A,765:169-179 (1997).
Kariya, Y. et al., “Disaccharide Analysis of Heparin and Heparan Sulfate Using Deaminative Cleavage with Nitrous Acid and Subsequent Labeling with Paranitrophenyl Hydrazine,”J. Biochem.(Tokyo), 123(2):240-6 (1998) Abstract Only.
Kinoshita, A. et al., “Microanalysis of Glycosaminoglycan-derived Oligosaccharides Labeled with a Fluorophore 2-aminobenzamide by High-performance Liquid Chromatography: Application to Disaccharide Composition Analysis of Exosequencing of Oligosaccharides,”Analytical Biochem.,269:367-378 (1999).
Lamari, F. et al., “Analysis of Glycosaminoglycan-derived Disaccharides in Biologic Samples by Capillary Electrophoresis and Protocol for Sequencing Glycosaminoglycans,”Biomedical Chromatography,16:95-102 (2002).
Lee, G. et al., “Separation of Reduced Disaccharides Derived from Glycosaminoglycans by High-performance Liquid Chromatography,”J. of Chromatography,212:65-73 (1981).
Lindhart, R. et al., “Mapping and Quantification of the Major Oligosaccharide Components of Heparin,”Biochem. Journal,254:781-787 (1988).
Linhardt, R. et al., “Oligosaccharide Mapping of Low Molecular Weight Heparins: Structure and Activity Differences,”J. of Medicinal Chem.,33(6):1639-1645 (1990).
Lindhardt, R. et al., “New Methodologies in Heparin Structure Analysis and the Generation of LMW Heparins,”Heparin and Related Polysaccharides,37-47, ed. D.A. Lane et al., Plenum Press, New York (1992).
Merchant, K. et al., “Structure of Heparin-derived Tetrasaccharides,” Biochem. Journal, 229:369-377 (1985).
Militsopoulou, M. et al., “Determination of 12 Heparin- and Heparan Sulfate-derived Disaccharides as 2-aminoacridone Derivatives by Capillary Zone Electrophoresis Using Ultraviolet and Laser-induced Flourescence Detection,”Electrophoresis,23:1104-1109 (2002).
Park, Y. et al., “Purification and Characterization of Heparin Sulphate Proteoglycan from Bovine Brain,” Biochem. Journal, 344:723-730 (1999).
Pervin, A. et al., “Separation of Glycosaminoglycan-derived Oligosaccharides by Capillary Electrophoresis Using Reverse Polarity,”Analytical Biochem.,221:182-188 (1994).
Rhomberg, A. et al., “Mass Spectrometric and Capillary Electrophoretic Investigation of the Enzymatic Degradation
Beccati Daniela
Capila Ishan
Gunay Nur Sibel
Ozug Jennifer
Shriver Zachary
Momenta Pharmaceuticals, Inc.
Wallenhorst Maureen M
LandOfFree
Evaluating mixtures of low molecular weight heparins by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Evaluating mixtures of low molecular weight heparins by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Evaluating mixtures of low molecular weight heparins by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4220779